Co-Delivery of Erlotinib and Resveratrol via Nanostructured Lipid Carriers: A Synergistically Promising Approach for Cell Proliferation Prevention and Ros-Mediated Apoptosis Activation
AuthID
P-00X-0YN
P-00X-0YN